Tasly ：rhPro-UK Phase II Data for Pulmonary Embolism Released
Remegen ：Telitacicept receives approval for dual indications.
Teva ：AJOVY®Fremanezumab-vfrmapproved for marketing in China.
Roche ：bexobrutideg has been in-licensed for development
Zenshine ：Jikeshu®Sebaloxavir Marboxil Tablets approved for marketing in China.
How much does Amaryl (Glimepiride Tablets) Cost& price without insurance in China?
How much does Yunzhi (Colchicine Tablets) Cost& price without insurance in China?
How much does Zhuoqing (Spectinomycin Hydrochloride for Injection) Cost& price without insurance in China?
Hengrui ：Aiweida®Trastuzumab RezetecanGranted Priority Review
Hengrui Medicine, Innovent Biologics, and Haisco Pharmaceutical: Bundling pipelines in out-licensing deals and Co-Co partnerships with global pharma giants, reshaping industry norms.
